Is RXRA or JNJ a better dividend investment in 2026?

RXRA currently yields 19.92% with a 5% 5-year dividend growth rate. JNJ yields 3.36% with 5.8% growth. The better choice depends on your goal: RXRA offers higher current income.

What is the dividend yield difference between RXRA and JNJ?

RXRA has a forward dividend yield of 19.92% ($2.00/share annually). JNJ yields 3.36% ($4.96/share annually). The yield gap is 16.56 percentage points.

Home › Compare › RXRA vs JNJ

RXRA vs JNJ: Dividend Comparison 2026

RXRA yields 19.92% · JNJ yields 3.36%● Live data

vsPost on X →

After 10 years · $10,000 invested · DRIP enabled

🏆 RXRA wins by $52.6K in total portfolio value

INVESTMENT

TIME HORIZON10 years

RXRA

● Live price

19.92%

Share price

$10.04

Annual div

$2.00

5Y div CAGR

Payout ratio

50%

After 10 yrs · $10,000 · DRIP

Portfolio value

$72.7K

Annual income

$6,681.84

Full RXRA calculator →

JNJ

Johnson & Johnson

● Live price

3.36%

Share price

$147.50

Annual div

$4.96

5Y div CAGR

5.8%

Payout ratio

55%

After 10 yrs · $10,000 · DRIP

Portfolio value

$20.0K

Annual income

$827.78

Full JNJ calculator →

Portfolio growth — RXRA vs JNJ

📍 RXRA pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis Period	RXRA	JNJ
2008–2009 GFC	— No data	— No data
2020 Q1–Q2 COVID	— No data	— No data
2022 Q4 Rate Hike	— No data	— No data

Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.

📅

Dividend Calendar Overlap

Combined, RXRA + JNJ cover 0 of 12 months — good coverage

Jan

—

Feb

—

Mar

—

Apr

—

May

—

Jun

—

Jul

—

Aug

—

Sep

—

Oct

—

Nov

—

Dec

—

RXRA pays

JNJ pays

Both pay

Neither

💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

RXRA

Annual income on $10K today (after 15% tax)

$1,693.23/yr

After 10yr DRIP, annual income (after tax)

$5,679.56/yr

JNJ

Annual income on $10K today (after 15% tax)

$285.83/yr

After 10yr DRIP, annual income (after tax)

$703.61/yr

At 15% tax rate, RXRA beats the other by $4,975.95/year in after-tax income after 10 years on $10,000

⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of RXRA + JNJ for your $10,000?

RXRA: 50%JNJ: 50%

100% JNJ50/50100% RXRA

Portfolio after 10yr

$46.3K

Annual income

$3,754.81/yr

Blended yield

8.10%

📊

Analyst Conviction Gap

Where Wall Street is most bullish on JNJ right now

RXRA

No analyst data

JNJ

Analyst Ratings

Buy

Hold

Sell

Consensus: Buy

Price Target

$228.73

+55.1% upside vs current

Range: $190.00 — $265.00

Altman Z

5.2

Piotroski

4/9

Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.

🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

RXRA buys

JNJ buys

No recent congressional trades found for RXRA or JNJ in the last 90 days.

STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →

MetricRXRAJNJ

Forward yield	19.92% ✓	3.36%
Annual dividend / share	$2.00	$4.96 ✓
Payout ratio	50% ✓	55%
1-year div growth	0%	4.2% ✓
5-year div CAGR	0%	5.8% ✓
Portfolio after 10y	$72.7K ✓	$20.0K
Annual income after 10y	$6,681.84 ✓	$827.78
Total dividends collected	$41.2K ✓	$5.6K
Payment frequency	quarterly	quarterly
Sector	Stock	Healthcare

Year-by-year: RXRA vs JNJ ($10,000, DRIP)

Year	RXRA Portfolio	RXRA Income/yr	JNJ Portfolio	JNJ Income/yr	Gap
1← crossover	$12,692	$1,992.03	$10,676	$355.77	+$2.0K → RXRA
2	$15,943	$2,362.89	$11,407	$389.39	+$4.5K → RXRA
3	$19,833	$2,774.01	$12,198	$426.53	+$7.6K → RXRA
4	$24,447	$3,225.09	$13,056	$467.62	+$11.4K → RXRA
5	$29,873	$3,715.22	$13,987	$513.12	+$15.9K → RXRA
6	$36,207	$4,242.88	$14,998	$563.56	+$21.2K → RXRA
7	$43,548	$4,806.07	$16,098	$619.52	+$27.4K → RXRA
8	$51,999	$5,402.29	$17,295	$681.69	+$34.7K → RXRA
9	$61,667	$6,028.62	$18,599	$750.82	+$43.1K → RXRA
10	$72,666	$6,681.84	$20,022	$827.78	+$52.6K → RXRA

RXRA vs JNJ: Complete Analysis 2026

RXRA — Stock

RXR Acquisition Corp. does not have significant operations. The company focuses on effecting a merger, share exchange, asset acquisition, share purchase, reorganization, or similar business combination with one or more businesses. It intends to acquire a company servicing the real estate industry. The company was incorporated in 2021 and is based in Uniondale, New York.

Full RXRA Calculator →

JNJ — Healthcare

Johnson & Johnson is a Dividend King with 62+ years of consecutive dividend increases. A healthcare conglomerate spanning pharmaceuticals, MedTech, and consumer health. JNJ spun off its consumer segment as Kenvue in 2023, focusing on higher-margin pharma and medical devices.

Full JNJ Calculator →

📬

Get this RXRA vs JNJ comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

RXRA vs SCHD RXRA vs JEPI RXRA vs O RXRA vs KO RXRA vs MAIN RXRA vs ABBV RXRA vs MRK RXRA vs PFE

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.